New antibody drug aims to outsmart aggressive lung cancer
Disease control
Recruiting now
This study tests a drug called tarlatamab in 39 people with extensive-stage small cell lung cancer, a fast-growing cancer that has spread. Tarlatamab is a special antibody that helps the body's immune cells find and attack cancer cells. The goal is to see if it can delay cancer g…
Phase: PHASE2 • Sponsor: Asrar Alahmadi • Aim: Disease control
Last updated May 26, 2026 12:09 UTC